These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Computerized tomography-guided fine needle biopsy. Current perspectives in biopsy diagnosis].
    Author: Verbeke CS, Bohrer MH, Wetzel E.
    Journal: Dtsch Med Wochenschr; 1993 Oct 01; 118(39):1389-94. PubMed ID: 8404488.
    Abstract:
    253 cutting needle biopsies from 240 patients (151 men, 89 women; mean age 68 [23-84] years) were reviewed. The biopsies were taken under computed (CT) tomography guidance from various parts of the body (pancreas: n = 48, liver: n = 32, other upper abdominal organs: n = 5, mediastinum: n = 27, lung: n = 37, kidney: n = 13, adrenals: n = 8, retroperitoneum: n = 35, pelvis: n = 37, pleura: n = 4, chest wall: n = 6). The data were evaluated retrospectively. In 86% of cases meaningful clinical information was obtained in the form of a definite diagnosis (74%) or of a presumptive or differential diagnosis (12%). As a rule it was possible to assess the degree of malignancy and to ascertain the exact nature of the condition; the latter was true not only of malignant but also of benign lesions. In the majority of cases this had important implications. In just under 14% of all cases the target area was missed and no diagnosis could be made. To raise the chances of obtaining a representative biopsy multiple punctures were performed in 44% of the CT-guided biopsies. In 61 cases (24%) the diagnosis was checked against further tissue samples and in four cases the diagnosis based on needle biopsy material had to be revised. In all, only two complications were recorded; both were mild and did not require treatment. In terms of diagnostic value, CT-guided fine needle biopsies proved considerably superior to conventional cytological studies of fine needle aspiration material.
    [Abstract] [Full Text] [Related] [New Search]